Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-84
Closed -$2K 7269
2014
Q4
$2K Hold
84
﹤0.01% 7086
2014
Q3
$2K Hold
84
﹤0.01% 7087
2014
Q2
$2K Sell
84
-2
-2% -$47 ﹤0.01% 6951
2014
Q1
$2K Hold
86
﹤0.01% 6739
2013
Q4
$2K Hold
86
﹤0.01% 6618
2013
Q3
$2K Buy
+86
New +$1.96K ﹤0.01% 6526

Other funds holding SNV

Goldman Sachs's SNV Position: Q1 2026 in Review

Goldman Sachs sold out of Synovus (SNV) in Q1 2026, closing a stake of 729,615 shares — an estimated $36.5M sold.

Goldman Sachs first reported a position in SNV in Q2 2013 and held it in 51 quarters. The position peaked at $89.8M in Q4 2018. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

  • Goldman Sachs reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
  • Goldman Sachs sold 729,615 Synovus shares in Q1 2026, an estimated $36.5M.
  • Goldman Sachs first reported a position in Synovus in Q2 2013 and held it in 51 quarters.
  • Goldman Sachs's Synovus position peaked at $89.8M in Q4 2018.
  • 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.